- Home
- MTH vs ACLX Comparison
MTH vs ACLX Comparison
Compare MTH & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTH
- ACLX
- Stock Information
- Founded
- MTH 1985
- ACLX 2015
- Country
- MTH United States
- ACLX United States
- Employees
- MTH N/A
- ACLX N/A
- Industry
- MTH Homebuilding
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- MTH Consumer Discretionary
- ACLX Health Care
- Exchange
- MTH Nasdaq
- ACLX Nasdaq
- Market Cap
- MTH 5.1B
- ACLX 4.1B
- IPO Year
- MTH 1988
- ACLX 2022
- Fundamental
- Price
- MTH $75.48
- ACLX $76.42
- Analyst Decision
- MTH Buy
- ACLX Strong Buy
- Analyst Count
- MTH 9
- ACLX 13
- Target Price
- MTH $86.88
- ACLX $114.75
- AVG Volume (30 Days)
- MTH 889.7K
- ACLX 507.4K
- Earning Date
- MTH 10-28-2025
- ACLX 11-06-2025
- Dividend Yield
- MTH 2.28%
- ACLX N/A
- EPS Growth
- MTH N/A
- ACLX N/A
- EPS
- MTH 8.78
- ACLX N/A
- Revenue
- MTH $6,216,250,000.00
- ACLX $56,979,000.00
- Revenue This Year
- MTH N/A
- ACLX N/A
- Revenue Next Year
- MTH $6.59
- ACLX $174.18
- P/E Ratio
- MTH $8.60
- ACLX N/A
- Revenue Growth
- MTH N/A
- ACLX N/A
- 52 Week Low
- MTH $59.27
- ACLX $47.86
- 52 Week High
- MTH $106.99
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- MTH 45.82
- ACLX 61.10
- Support Level
- MTH $77.85
- ACLX $73.16
- Resistance Level
- MTH $81.22
- ACLX $78.61
- Average True Range (ATR)
- MTH 2.43
- ACLX 2.84
- MACD
- MTH -0.67
- ACLX 0.55
- Stochastic Oscillator
- MTH 7.58
- ACLX 75.42
About MTH Meritage Homes Corporation
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.